Shahin Nozohoor, Jan-Ingmar Flock, Anders Heimdahl

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents

In-vitro interaction of azithromycin and fluoroquinolones against gram-positive and gram-negative bacteria Matthew W. Ruble, Deborah H. Gilbert, Stephen.

Grepafloxacin: microbiological properties

I.J. Schalk Clinical Microbiology and Infection

Approach to diagnosis of infective endocarditis

Incidence and outcome of Staphylococcus aureus endocarditis—a 10-year single-centre northern European experience H. Asgeirsson, A. Thalme, M. Kristjansson,

Molecular characterization of methicillin-resistant Staphylococcus aureus isolated over a 2-year period in a Qatari hospital from multinational patients

The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram- positive bacteria M.J. Rybak Clinical Microbiology and Infection

Herpes zoster in non-hospitalized children

Use of antimicrobials and resistance in bacteria isolated from blood cultures in a Danish county from 1992 to 1995 Thomas Lund S⊘rensen, Niels Frimodt-M⊘ller,

Hydatid disease Clinical Microbiology and Infection

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

Revision of linezolid disk diffusion quality control guidelines for testing Staphylococcus aureus ATCC 25923: an independent seven-laboratory trial D.J.

Outcome and predictors of treatment failure in early post-surgical prosthetic joint infections due to Staphylococcus aureus treated with debridement

Inflammatory response and clinical course of adult patients with nosocomial bloodstream infections caused by Candida spp. H. Wisplinghoff, H. Seifert,

How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach D. Guillemot Clinical Microbiology.

In vitro activity, postantibiotic effect and human monocyte activity of grepafloxacin against Legionella species Jacques Dubois, Claude St-Pierre Clinical.

Quadri-valvular endocarditis caused by Streptococcus mutans

Holt Hanne M. , Søgaard Per , Gahrn-Hansen Bente

Structure of grepafloxacin relative to activity and safety profile

Vector control: a cornerstone in the malaria elimination campaign

Pharmacodynamics of doxycycline

Inga Odenholt, Elisabeth Löwdin, Otto Cars

G. Sakoulas Clinical Microbiology and Infection

C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins

Sofie Arens, Jan Verhaegen, Ludo Verbist

Training for the infectious diseases speciality in Norway

Development of antimicrobial resistance in Staphylococcus lugdunensis during treatment—report of a case of bacterial arthritis, vertebral osteomyelitis.

Cephalosporins: a pharmacological update

Low prevalence of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in Belgian hospitals C. Nonhoff, O. Denis,

Epidemiology of opportunistic infections in AIDS patients

Laboratory diagnosis and biosafety issues of biological warfare agents

Bacterial resistance—the clinical challenge

Rapidly progressive tricuspid valve endocarditis caused by Capnocytophaga canimorsus infection in an immunocompetent host A.J. Kooter, A. Derks, W.L.E.

Comparative in vitro pharmacodynamics of BO-2727, meropenem and imipenem against Gram-positive and Gram-negative bacteria Inga Odenholt, Elisabeth Löwdin,

Sepsis and neutropenia induced by clozapine

Uncommon opportunistic fungi: new nosocomial threats

Multi-valvular endocarditis

André Bryskier Clinical Microbiology and Infection

Metagenomics and probiotics

M. Aires-de-Sousa Clinical Microbiology and Infection

Effect of antioxidants on the immune response of Helicobacter pylori

Erythromycin susceptibility of viridans streptococci from the normal throat flora of patients treated with azithromycin or clarithromycin King A. , Bathgate.

Laboratory diagnosis of Clostridium difficile disease

Recent developments in staphylococcal scalded skin syndrome

Interactions between cytomegalovirus and the p53 tumor suppressor gene in atherosclerotic vascular disease Inge O. Baas, G. Johan A. Offerhaus, Ralph.

Community-acquired pneumonia: epidemiologic and clinical consideration

Abstracts cont. Clinical Microbiology and Infection

Training in infectious diseases and tropical medicine in Britain

Fibronectin concentrations in catheter sepsis

Clinical infection services—the Leiden experience

Sequential time to positivity of blood cultures can be a predictor of prognosis of patients with persistent Staphylococcus aureus bacteraemia M.-S. Hsu,

European guidelines for diagnosis and management of patients with suspected herpes simplex encephalitis Miles Denton, Kevin G Kerr, Fraser Lewis Clinical.

Clinical Microbiology and Infection

Empiric therapy of bacterial infections in severe neutropenia

Overview of cefixime use in community-acquired infections

Sanford Chodosh Clinical Microbiology and Infection

Granulocyte colony-stimulating factor (G-CSF) and interleukin (IL)-8 in sera from patients with Staphylococcus aureus septicemia Bo Söderquist, Dan Danielsson,

Panton–Valentine leukocidin-encoding bacteriophage and gene sequence variation in community-associated methicillin-resistant Staphylococcus aureus J.A.

Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe Robert D. Fox Clinical Microbiology.

Abstracts Clinical Microbiology and Infection

Virology: a scientific discipline facing new challenges

New oral cephalosporins in pediatric community-acquired infections

Evaluation of the BBL CrystalTM MRSA ID System for Rapid Detection of Methicillin Resistance in Staphylococcus aureus Sylvie Dutka-Malen, Murielle Charles,

A. Manzur, F. Gudiol Clinical Microbiology and Infection

B.A. Cunha Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

The future of diagnostic bacteriology

Vincent Calvez, Marc Grandadam Clinical Microbiology and Infection

Presentation transcript:

Experimental endocarditis in the rat secondary to septic arthritis induced by Staphylococcus aureus Shahin Nozohoor, Jan-Ingmar Flock, Anders Heimdahl Clinical Microbiology and Infection Volume 5, Issue 3, Pages 158-163 (March 1999) DOI: 10.1111/j.1469-0691.1999.tb00529.x Copyright © 1999 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 1 Log number of bacteria/mL blood for each animal, 6 (n= 3), 7 (n= 4), and 8 (n= 3) days after induction of septic arthritis. Clinical Microbiology and Infection 1999 5, 158-163DOI: (10.1111/j.1469-0691.1999.tb00529.x) Copyright © 1999 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 2 Log number of total bacteria recovered from both TMJs. spleen and aortic valve 24 h post-catheterization and 8 days post-challenge with 107 CFU of Phillips and 1 mg intra-articular injection of triamcinolone acetonide. Bars indicate mean values±SD. Clinical Microbiology and Infection 1999 5, 158-163DOI: (10.1111/j.1469-0691.1999.tb00529.x) Copyright © 1999 European Society of Clinical Infectious Diseases Terms and Conditions